Bill · S. 3346· Senate(119-S-3346)
Freedom to Heal Act of 2025
- Introduced
- 12/4/2025
- Last activity
- 12/4/2025 — Read twice and referred to the Committee on the Judiciary.
- Sponsored by
- Cory Booker
- Cosponsors
- - 1 - 1
- Introduced
- In Committee
What this bill would do
The "Freedom to Heal Act of 2025" aims to create a special registration process under the Controlled Substances Act. This allows physicians to directly administer schedule I eligible investigational drugs to patients under the Federal Right to Try law. The Attorney General is tasked with managing this registration process. Physicians must meet specific requirements, including providing evidence of valid registration for other substances and compliance with existing laws. The bill also outlines how physicians can request additional amounts of drugs and how they can use a single registration for multiple related sites. Finally, it mandates the creation of specific rules regarding the delivery, storage, and security of these drugs.
Yes
Does this make health care easier to get in general?+7
The bill expands access to investigational drugs for eligible patients through a new registration process for physicians.
Would people with disabilities be better off under this?+1
The bill may benefit patients with severe conditions who are eligible for Right to Try protocols.
The opposite
Does this make what the government does easier for the public to see?-2
The bill grants the Attorney General significant administrative authority over the registration and security of drug distribution.
Who it would affect, and how
Potential Positive Impacts for People
-
Access to investigational drugs: The bill allows physicians to directly administer schedule I eligible investigational drugs to eligible patients under the Federal Right to Try law (Section 2, paragraph 2).
-
Streamlined registration for multiple locations: Physicians can use a single registration to treat patients across multiple sites if those sites are within the same city or county and under the same control (Section 2, paragraph 6).
-
Flexibility in drug supply: Physicians have a mechanism to request additional quantities of a drug through a supplemental notification process (Section 2, paragraph 5).
Potential Negative Impacts for People
-
Strict application requirements: Physicians face a heavy burden of proof, needing to provide evidence of valid registrations for other substances, compliance documentation from manufacturers, and proof that they can treat patients under state laws (Section 2, paragraph 3).
-
Regulatory oversight and potential for investigation: The Attorney General has the authority to serve an "order to show cause" upon applicants during both the initial registration and supplemental notification processes (Section 2, paragraph 3 and paragraph 5).
-
Limitations on drug possession: Physicians are restricted to possessing only the amounts of the drug identified in their initial application or their supplemental notifications (Section 2, paragraph 5).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Healthcare Access+7
- Governance And Ideology
- Improves Government Transparency-2
- Demographic And Interest Groups
- Good For People With Disabilities+1
- 2/11/2026
- 1 Cosponsor added.
- 12/4/2025
- Read twice and referred to the Committee on the Judiciary.
- 1 Cosponsor added.
- Introduced in Senate
2 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Martin HeinrichDemocrat · New Mexico
Rand PaulRepublican · Kentucky